# Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)

> **NCT05067478** · — · COMPLETED · sponsor: **Urovant Sciences GmbH** · enrollment: 403 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Vibegron

## Key facts

- **NCT ID:** NCT05067478
- **Lead sponsor:** Urovant Sciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-28
- **Primary completion:** 2024-07-22
- **Final completion:** 2024-07-26
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05067478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05067478, "Composur: Study to Understand the Performance of Vibegron in Participants with Overactive Bladder (OAB)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05067478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*